These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
454 related articles for article (PubMed ID: 18353662)
1. Abeta-globulomers are formed independently of the fibril pathway. Gellermann GP; Byrnes H; Striebinger A; Ullrich K; Mueller R; Hillen H; Barghorn S Neurobiol Dis; 2008 May; 30(2):212-20. PubMed ID: 18353662 [TBL] [Abstract][Full Text] [Related]
2. Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease. Barghorn S; Nimmrich V; Striebinger A; Krantz C; Keller P; Janson B; Bahr M; Schmidt M; Bitner RS; Harlan J; Barlow E; Ebert U; Hillen H J Neurochem; 2005 Nov; 95(3):834-47. PubMed ID: 16135089 [TBL] [Abstract][Full Text] [Related]
3. [Involvement of beta-amyloid in the etiology of Alzheimer's disease]. Tomiyama T Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873 [TBL] [Abstract][Full Text] [Related]
4. Metal ions differentially influence the aggregation and deposition of Alzheimer's beta-amyloid on a solid template. Ha C; Ryu J; Park CB Biochemistry; 2007 May; 46(20):6118-25. PubMed ID: 17455909 [TBL] [Abstract][Full Text] [Related]
5. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain. Güntert A; Döbeli H; Bohrmann B Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022 [TBL] [Abstract][Full Text] [Related]
6. Oligomers of beta-amyloid are sequestered into and seed new plaques in the brains of an AD mouse model. Gaspar RC; Villarreal SA; Bowles N; Hepler RW; Joyce JG; Shughrue PJ Exp Neurol; 2010 Jun; 223(2):394-400. PubMed ID: 19744481 [TBL] [Abstract][Full Text] [Related]
7. Amyloid-beta aggregation. Finder VH; Glockshuber R Neurodegener Dis; 2007; 4(1):13-27. PubMed ID: 17429215 [TBL] [Abstract][Full Text] [Related]
8. Ex situ atomic force microscopy analysis of beta-amyloid self-assembly and deposition on a synthetic template. Ha C; Park CB Langmuir; 2006 Aug; 22(16):6977-85. PubMed ID: 16863248 [TBL] [Abstract][Full Text] [Related]
9. Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's disease. Gouras GK; Almeida CG; Takahashi RH Neurobiol Aging; 2005 Oct; 26(9):1235-44. PubMed ID: 16023263 [TBL] [Abstract][Full Text] [Related]
10. Docosahexaenoic acid disrupts in vitro amyloid beta(1-40) fibrillation and concomitantly inhibits amyloid levels in cerebral cortex of Alzheimer's disease model rats. Hashimoto M; Shahdat HM; Yamashita S; Katakura M; Tanabe Y; Fujiwara H; Gamoh S; Miyazawa T; Arai H; Shimada T; Shido O J Neurochem; 2008 Dec; 107(6):1634-46. PubMed ID: 19014387 [TBL] [Abstract][Full Text] [Related]
11. Small molecule beta-amyloid inhibitors that stabilize protofibrillar structures in vitro improve cognition and pathology in a mouse model of Alzheimer's disease. Hawkes CA; Deng LH; Shaw JE; Nitz M; McLaurin J Eur J Neurosci; 2010 Jan; 31(2):203-13. PubMed ID: 20074226 [TBL] [Abstract][Full Text] [Related]
12. Isoaspartate formation at position 23 of amyloid beta peptide enhanced fibril formation and deposited onto senile plaques and vascular amyloids in Alzheimer's disease. Shimizu T; Fukuda H; Murayama S; Izumiyama N; Shirasawa T J Neurosci Res; 2002 Nov; 70(3):451-61. PubMed ID: 12391606 [TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid of Alzheimer patients promotes beta-amyloid fibril formation in vitro. Ono K; Noguchi M; Matsumoto Y; Yanase D; Iwasa K; Naiki H; Yamada M Neurobiol Dis; 2005 Nov; 20(2):233-40. PubMed ID: 16242632 [TBL] [Abstract][Full Text] [Related]
14. Small heat shock proteins inhibit amyloid-beta protein aggregation and cerebrovascular amyloid-beta protein toxicity. Wilhelmus MM; Boelens WC; Otte-Höller I; Kamps B; de Waal RM; Verbeek MM Brain Res; 2006 May; 1089(1):67-78. PubMed ID: 16635482 [TBL] [Abstract][Full Text] [Related]
15. Binding of cystatin C to Alzheimer's amyloid beta inhibits in vitro amyloid fibril formation. Sastre M; Calero M; Pawlik M; Mathews PM; Kumar A; Danilov V; Schmidt SD; Nixon RA; Frangione B; Levy E Neurobiol Aging; 2004 Sep; 25(8):1033-43. PubMed ID: 15212828 [TBL] [Abstract][Full Text] [Related]
16. Development of a proteolytically stable retro-inverso peptide inhibitor of beta-amyloid oligomerization as a potential novel treatment for Alzheimer's disease. Taylor M; Moore S; Mayes J; Parkin E; Beeg M; Canovi M; Gobbi M; Mann DM; Allsop D Biochemistry; 2010 Apr; 49(15):3261-72. PubMed ID: 20230062 [TBL] [Abstract][Full Text] [Related]
18. Phosphatidylinositol and inositol involvement in Alzheimer amyloid-beta fibril growth and arrest. McLaurin J; Franklin T; Chakrabartty A; Fraser PE J Mol Biol; 1998 Apr; 278(1):183-94. PubMed ID: 9571042 [TBL] [Abstract][Full Text] [Related]
19. A possible model of senile plaques using synthetic amyloid beta-protein and rat glial culture. Isobe I; Yanagisawa K; Michikawa M Exp Neurol; 2000 Mar; 162(1):51-60. PubMed ID: 10716888 [TBL] [Abstract][Full Text] [Related]
20. Linker histone H1 binds to disease associated amyloid-like fibrils. Duce JA; Smith DP; Blake RE; Crouch PJ; Li QX; Masters CL; Trounce IA J Mol Biol; 2006 Aug; 361(3):493-505. PubMed ID: 16854430 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]